As Nike approaches its quarterly earnings release, a palpable tension hangs over the market. This comes despite recent cautious guidance from the company’s own leadership. A notable counterpoint to the prevailing skepticism is emerging from several analyst firms, who are reaffirming their positive stance on the athletic apparel giant’s stock.
Institutional Support Amid Market Caution
Leading the optimistic charge is RBC Capital Markets, which recently reiterated its buy recommendation on Nike shares. This endorsement arrives at a crucial juncture, following a period of significant share price depreciation and just before the company’s financial update. The affirmation provides a measure of support against the broader market’s wary sentiment. Further analysis from Zacks Investment Research also highlighted Nike, suggesting the stock holds potential value at current levels, even as it trades substantially below its 52-week high. However, institutional investors appear to be adopting a wait-and-see approach for now, with the pre-earnings risk premium considered elevated.
Fundamental Challenges Test Resilience
The analysts’ confidence is being tested by a complex operational backdrop. Nike is currently navigating its fiscal 2026 year while executing a comprehensive “Win Now” strategy focused on digital optimization and inventory efficiency. Progress, however, has been slower than anticipated, with management already forecasting a slight revenue decline for the past quarter.
Should investors sell immediately? Or is it worth buying Nike?
Two primary headwinds are impeding a faster recovery:
* Chinese Market Volatility: An uneven economic rebound in the critical Chinese market continues to suppress sales performance in the region.
* Strategic Pricing Shift: A deliberate reduction in discounting activity to protect brand exclusivity is weighing on short-term sales volume.
These specific challenges are reflected in Nike’s year-to-date stock decline of over 21%, underscoring concerns that the company’s turnaround may be more protracted than initially hoped. A sector comparison reveals that Nike is facing greater pressure than some competitors, such as Lululemon, which have demonstrated more agility in adapting to recent consumer trends.
The December Catalyst
All eyes are now fixed on December 18, 2025, the scheduled date for Nike’s quarterly results. Investor focus is expected to shift away from the already-telegraphed top-line figures and instead zero in on gross margin performance and, more importantly, the guidance for the second half of the fiscal year. For the stock to mount a sustained recovery, Nike will need to deliver convincing results and articulate a credible roadmap for returning to growth in 2026. A strong showing on these fronts could provide the necessary catalyst for a reversal in sentiment.
Ad
Nike Stock: Buy or Sell?! New Nike Analysis from December 7 delivers the answer:
The latest Nike figures speak for themselves: Urgent action needed for Nike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 7.
Nike: Buy or sell? Read more here...
